Latest Insider Transactions at Sera Prognostics, Inc. (SERA)
This section provides a real-time view of insider transactions for Sera Prognostics, Inc. (SERA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SERA PROGNOSTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SERA PROGNOSTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-2.85%
|
$8,175
$3.73 P/Share
|
|
Mar 22
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-2.77%
|
$8,175
$3.68 P/Share
|
|
Mar 14
2022
|
John J. Boniface Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,725
-2.7%
|
$8,175
$3.94 P/Share
|
|
Mar 11
2022
|
John J. Boniface Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,998
+42.93%
|
$0
$0.73 P/Share
|
|
Dec 06
2021
|
John J. Boniface Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,012
+50.0%
|
$0
$0.73 P/Share
|
|
Jul 19
2021
|
Blue Ox Healthcare Partners, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,795,150
+50.0%
|
-
|
|
Jul 19
2021
|
Joshua Phillips Director |
BUY
Conversion of derivative security
|
Indirect |
927,562
+12.86%
|
-
|
|
Jul 19
2021
|
Ryan Trimble Director |
BUY
Conversion of derivative security
|
Indirect |
63,005
+13.72%
|
-
|
|
Jul 19
2021
|
Gregory C Critchfield Director |
BUY
Conversion of derivative security
|
Direct |
84,973
+2.15%
|
-
|
|
Jul 19
2021
|
Jay M Moyes Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
2,830
+30.85%
|
-
|